Plexus (NASDAQ:PLXS) CEO Todd Kelsey Sells 1,500 Shares

16 Apr 2026, 17:26 by Scott Moore · The Cerbat Gem

Plexus Corp. (NASDAQ:PLXS – Get Free Report) CEO Todd Kelsey sold 1,500 shares of the business’s stock in a transaction that occurred on Wednesday, April 15th. The stock was sold at an average price of $224.09, for a total transaction of $336,135.00. Following the sale, the chief executive officer owned 80,291 shares of the company’s stock, valued at approximately $17,992,410.19. This represents a 1.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Plexus Trading Up 1.1%

PLXS traded up $2.39 during trading on Thursday, hitting $222.88. 283,697 shares of the company’s stock were exchanged, compared to its average volume of 347,636. The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 0.06. Plexus Corp. has a 1 year low of $115.35 and a 1 year high of $232.17. The stock has a 50 day moving average price of $202.69 and a 200 day moving average price of $171.17. The firm has a market cap of $5.97 billion, a P/E ratio of 34.66 and a beta of 0.75.

Plexus (NASDAQ:PLXS – Get Free Report) last released its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.77 by $0.01. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The company had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.07 billion. During the same period in the previous year, the firm earned $1.73 earnings per share. Plexus’s revenue for the quarter was up 9.6% on a year-over-year basis. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. As a group, analysts expect that Plexus Corp. will post 5.9 EPS for the current fiscal year.

More Plexus News

Here are the key news stories impacting Plexus this week:

Positive Sentiment: Plexus was highlighted for hitting a fresh high as Nasdaq momentum lifted the shares, supporting near-term upside and investor sentiment. Plexus Hits Fresh High
Neutral Sentiment: Plexus announced its fiscal Q2 2026 results release date (after market close Apr. 29) and a conference call on Apr. 30 — an event to watch that can drive volatility and give fresh guidance. Earnings Release Date
Negative Sentiment: Zacks Research downgraded Plexus from “strong-buy” to “hold” and trimmed several EPS forecasts (small cuts to Q1 2027, Q4 2027, FY2027, FY2028 and FY2026; a tiny raise to Q3 2027). The cumulative effect is a modest negative catalyst that could temper upside ahead of results. Zacks Downgrades Plexus

Institutional Trading of Plexus

A number of large investors have recently modified their holdings of PLXS. AQR Capital Management LLC increased its holdings in shares of Plexus by 103.1% in the 1st quarter. AQR Capital Management LLC now owns 8,384 shares of the technology company’s stock worth $1,074,000 after acquiring an additional 4,255 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Plexus by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,971 shares of the technology company’s stock worth $2,046,000 after acquiring an additional 705 shares during the period. United Services Automobile Association acquired a new stake in shares of Plexus in the 1st quarter worth about $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Plexus by 12.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 79,584 shares of the technology company’s stock worth $10,197,000 after acquiring an additional 9,078 shares during the period. Finally, Cetera Investment Advisers acquired a new stake in shares of Plexus in the 2nd quarter worth about $309,000. Institutional investors and hedge funds own 94.45% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently weighed in on PLXS. Williams Trading set a $195.00 target price on shares of Plexus in a research note on Wednesday, January 28th. Weiss Ratings upgraded shares of Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, March 6th. Stifel Nicolaus upped their target price on shares of Plexus from $150.00 to $200.00 and gave the company a “hold” rating in a research note on Friday, January 30th. Wall Street Zen downgraded shares of Plexus from a “buy” rating to a “hold” rating in a research note on Sunday, March 8th. Finally, Benchmark restated a “buy” rating and issued a $220.00 target price on shares of Plexus in a research note on Monday, March 16th. Three investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Plexus presently has an average rating of “Moderate Buy” and an average price target of $194.20.

Read Our Latest Analysis on PLXS

About Plexus

(Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.